Inotropic and vasoactive drugs for management of the critically ill.
I have reviewed the identifiable hemodynamic effects of selected inotropic and vasoactive agents in the context of several clinical patient subsets. Knowledge of relative hemodynamic effects of various agents permits the selection of those that are best in specific clinical circumstances. Combining drugs may only occasionally be advisable to supplement a desired effect or to attenuate an unwanted one.
McGrath
R B
RB
Department of Medicine, Wishard Memorial Hospital, Indiana University Medical Center, Regenstrief Health Center, Indianapolis.
D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D003422:Critical Care; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D010101:Oxygen Consumption / Q000187:drug effects; D012769:Shock / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D002316:Cardiotonic Agents; D014665:Vasodilator Agents